Clinical Trial Update: Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and efficacy of ceftaroline in pediatric patients with late-onset sepsis; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-onset Sepsis

Drugs mentioned

• ceftaroline (ceftaroline fosamil)

Snippet

Sponsor: Pfizer | Conditions: Late-onset Sepsis | Phase 2 | Status: TERMINATED | Results posted: 2018-07-17